GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maat Pharma SA (XPAR:MAAT) » Definitions » PB Ratio

Maat Pharma (XPAR:MAAT) PB Ratio : 4.45 (As of Jun. 07, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Maat Pharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-07), Maat Pharma's share price is €7.86. Maat Pharma's Book Value per Share for the quarter that ended in Dec. 2023 was €1.77. Hence, Maat Pharma's PB Ratio of today is 4.45.

The historical rank and industry rank for Maat Pharma's PB Ratio or its related term are showing as below:

XPAR:MAAT' s PB Ratio Range Over the Past 10 Years
Min: 1.93   Med: 2.95   Max: 5.37
Current: 4.46

During the past 6 years, Maat Pharma's highest PB Ratio was 5.37. The lowest was 1.93. And the median was 2.95.

XPAR:MAAT's PB Ratio is ranked worse than
73.14% of 1307 companies
in the Biotechnology industry
Industry Median: 2.51 vs XPAR:MAAT: 4.46

During the past 12 months, Maat Pharma's average Book Value Per Share Growth Rate was -34.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -51.50% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Maat Pharma was 48.50% per year. The lowest was -51.50% per year. And the median was -1.50% per year.

Back to Basics: PB Ratio


Maat Pharma PB Ratio Historical Data

The historical data trend for Maat Pharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maat Pharma PB Ratio Chart

Maat Pharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial - 9.43 3.31 2.97 3.95

Maat Pharma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.31 3.35 2.97 2.68 3.95

Competitive Comparison of Maat Pharma's PB Ratio

For the Biotechnology subindustry, Maat Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maat Pharma's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maat Pharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Maat Pharma's PB Ratio falls into.



Maat Pharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Maat Pharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=7.86/1.765
=4.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Maat Pharma  (XPAR:MAAT) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Maat Pharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Maat Pharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Maat Pharma (XPAR:MAAT) Business Description

Traded in Other Exchanges
Address
70 Avenue Tony Garnier, Lyon, FRA, 69007
Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Maat Pharma (XPAR:MAAT) Headlines

No Headlines